These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 28647208)
41. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients. Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689 [TBL] [Abstract][Full Text] [Related]
42. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Zhang XG; Song BT; Liu FJ; Sun D; Wang KX; Qu H Clin Transl Oncol; 2016 Jul; 18(7):700-7. PubMed ID: 26489425 [TBL] [Abstract][Full Text] [Related]
44. Low expression of PDHA1 predicts poor prognosis in gastric cancer. Song L; Liu D; Zhang X; Zhu X; Lu X; Huang J; Yang L; Wu Y Pathol Res Pract; 2019 Mar; 215(3):478-482. PubMed ID: 30611622 [TBL] [Abstract][Full Text] [Related]
45. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer. Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801 [TBL] [Abstract][Full Text] [Related]
46. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Jang BG; Lee BL; Kim WH Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873 [TBL] [Abstract][Full Text] [Related]
47. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. Cheng S; Liu W; Mercado M; Ezzat S; Asa SL Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683 [TBL] [Abstract][Full Text] [Related]
48. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy. Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248 [TBL] [Abstract][Full Text] [Related]
49. New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma. Liu F; Shen D; Kang X; Zhang C; Song Q J Clin Pathol; 2015 Nov; 68(11):913-6. PubMed ID: 26157147 [TBL] [Abstract][Full Text] [Related]
50. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients. Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229 [TBL] [Abstract][Full Text] [Related]
51. Prognostic value of miR-141 downregulation in gastric cancer. Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225 [TBL] [Abstract][Full Text] [Related]
52. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma. Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095 [TBL] [Abstract][Full Text] [Related]
53. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker. Zhang M; Zhang C; Du W; Yang X; Chen Z Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032 [TBL] [Abstract][Full Text] [Related]
54. Expression of the MAGE gene family in human gastric carcinoma. Li J; Yang Y; Fujie T; Tanaka F; Mimori K; Haraguchi M; Ueo H; Mori M; Akiyoshi T Anticancer Res; 1997; 17(5A):3559-63. PubMed ID: 9413202 [TBL] [Abstract][Full Text] [Related]
55. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949 [TBL] [Abstract][Full Text] [Related]
56. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer. Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652 [TBL] [Abstract][Full Text] [Related]
57. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma. Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104 [TBL] [Abstract][Full Text] [Related]
58. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer. Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193 [TBL] [Abstract][Full Text] [Related]
59. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827 [TBL] [Abstract][Full Text] [Related]
60. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma. Sarcevic B; Spagnoli GC; Terracciano L; Schultz-Thater E; Heberer M; Gamulin M; Krajina Z; Oresic T; Separovic R; Juretic A Oncology; 2003; 64(4):443-9. PubMed ID: 12759544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]